EVERUS CONSTRUCTION GROUP (ECG) Stock Fundamental Analysis

NYSE:ECG • US3004261034

134.49 USD
+30.28 (+29.06%)
Last: Feb 25, 2026, 01:04 PM
Fundamental Rating

4

Overall ECG gets a fundamental rating of 4 out of 10. We evaluated ECG against 55 industry peers in the Construction & Engineering industry. ECG has an excellent financial health rating, but there are some minor concerns on its profitability. ECG has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year ECG was profitable.
  • In the past year ECG had a positive cash flow from operations.
  • ECG had positive earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: ECG reported negative operating cash flow in multiple years.
ECG Yearly Net Income VS EBIT VS OCF VS FCFECG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 11.14%, ECG is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
  • ECG has a Return On Equity of 31.58%. This is amongst the best in the industry. ECG outperforms 81.82% of its industry peers.
  • With an excellent Return On Invested Capital value of 19.09%, ECG belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
  • ECG had an Average Return On Invested Capital over the past 3 years of 19.20%. This is above the industry average of 17.02%.
Industry RankSector Rank
ROA 11.14%
ROE 31.58%
ROIC 19.09%
ROA(3y)11.72%
ROA(5y)N/A
ROE(3y)32.38%
ROE(5y)N/A
ROIC(3y)19.2%
ROIC(5y)N/A
ECG Yearly ROA, ROE, ROICECG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 10 20 30

1.3 Margins

  • ECG's Profit Margin of 5.18% is fine compared to the rest of the industry. ECG outperforms 61.82% of its industry peers.
  • ECG's Profit Margin has declined in the last couple of years.
  • The Operating Margin of ECG (6.92%) is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of ECG has declined.
  • With a Gross Margin value of 12.10%, ECG is not doing good in the industry: 67.27% of the companies in the same industry are doing better.
  • ECG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.92%
PM (TTM) 5.18%
GM 12.1%
OM growth 3Y-2.11%
OM growth 5YN/A
PM growth 3Y-1.91%
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5YN/A
ECG Yearly Profit, Operating, Gross MarginsECG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2 4 6 8 10

7

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ECG is creating value.
  • ECG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ECG Yearly Shares OutstandingECG Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M 40M 50M
ECG Yearly Total Debt VS Total AssetsECG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • ECG has an Altman-Z score of 6.44. This indicates that ECG is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of ECG (6.44) is better than 81.82% of its industry peers.
  • The Debt to FCF ratio of ECG is 2.14, which is a good value as it means it would take ECG, 2.14 years of fcf income to pay off all of its debts.
  • ECG has a Debt to FCF ratio of 2.14. This is in the better half of the industry: ECG outperforms 78.18% of its industry peers.
  • A Debt/Equity ratio of 0.47 indicates that ECG is not too dependend on debt financing.
  • The Debt to Equity ratio of ECG (0.47) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 2.14
Altman-Z 6.44
ROIC/WACC2.08
WACC9.18%
ECG Yearly LT Debt VS Equity VS FCFECG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 1.76 indicates that ECG should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.76, ECG belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
  • A Quick Ratio of 1.69 indicates that ECG should not have too much problems paying its short term obligations.
  • With an excellent Quick ratio value of 1.69, ECG belongs to the best of the industry, outperforming 87.27% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.69
ECG Yearly Current Assets VS Current LiabilitesECG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 200M 400M 600M 800M

1

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.19%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%33.15%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.99% on average over the next years.
  • ECG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.45% yearly.
EPS Next Y0.7%
EPS Next 2Y5.4%
EPS Next 3Y11.93%
EPS Next 5Y7.99%
Revenue Next Year8.94%
Revenue Next 2Y8.67%
Revenue Next 3Y13.22%
Revenue Next 5Y5.45%

3.3 Evolution

ECG Yearly Revenue VS EstimatesECG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
ECG Yearly EPS VS EstimatesECG Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

2

4. Valuation

4.1 Price/Earnings Ratio

  • ECG is valuated quite expensively with a Price/Earnings ratio of 34.13.
  • Based on the Price/Earnings ratio, ECG is valued a bit cheaper than the industry average as 76.36% of the companies are valued more expensively.
  • ECG is valuated rather expensively when we compare the Price/Earnings ratio to 26.98, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 33.90, which means the current valuation is very expensive for ECG.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ECG indicates a somewhat cheap valuation: ECG is cheaper than 70.91% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of ECG to the average of the S&P500 Index (28.01), we can say ECG is valued slightly more expensively.
Industry RankSector Rank
PE 34.13
Fwd PE 33.9
ECG Price Earnings VS Forward Price EarningsECG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as ECG.
  • Based on the Price/Free Cash Flow ratio, ECG is valued a bit cheaper than the industry average as 63.64% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 51.41
EV/EBITDA 20.19
ECG Per share dataECG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)48.7
PEG (5Y)N/A
EPS Next 2Y5.4%
EPS Next 3Y11.93%

0

5. Dividend

5.1 Amount

  • No dividends for ECG!.
Industry RankSector Rank
Dividend Yield 0%

EVERUS CONSTRUCTION GROUP

NYSE:ECG (2/25/2026, 1:04:08 PM)

134.49

+30.28 (+29.06%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)02-24
Earnings (Next)05-11
Inst Owners87.93%
Inst Owner Change4.71%
Ins Owners0.3%
Ins Owner Change0.15%
Market Cap6.86B
Revenue(TTM)N/A
Net Income(TTM)180.96M
Analysts76.36
Price Target106.28 (-20.98%)
Short Float %3.88%
Short Ratio3.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)75.29%
Min EPS beat(2)72.75%
Max EPS beat(2)77.83%
EPS beat(4)3
Avg EPS beat(4)53.11%
Min EPS beat(4)-3.53%
Max EPS beat(4)77.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)20.59%
Min Revenue beat(2)17.63%
Max Revenue beat(2)23.55%
Revenue beat(4)4
Avg Revenue beat(4)18.41%
Min Revenue beat(4)11.43%
Max Revenue beat(4)23.55%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.39%
PT rev (3m)-1.39%
EPS NQ rev (1m)4.97%
EPS NQ rev (3m)4.97%
EPS NY rev (1m)0.8%
EPS NY rev (3m)23.61%
Revenue NQ rev (1m)1.82%
Revenue NQ rev (3m)1.82%
Revenue NY rev (1m)0.36%
Revenue NY rev (3m)7.01%
Valuation
Industry RankSector Rank
PE 34.13
Fwd PE 33.9
P/S 1.96
P/FCF 51.41
P/OCF 36.23
P/B 11.97
P/tB 15.96
EV/EBITDA 20.19
EPS(TTM)3.94
EY2.93%
EPS(NY)3.97
Fwd EY2.95%
FCF(TTM)2.62
FCFY1.95%
OCF(TTM)3.71
OCFY2.76%
SpS68.51
BVpS11.23
TBVpS8.43
PEG (NY)48.7
PEG (5Y)N/A
Graham Number31.56
Profitability
Industry RankSector Rank
ROA 11.14%
ROE 31.58%
ROCE 25.96%
ROIC 19.09%
ROICexc 22.73%
ROICexgc 27.82%
OM 6.92%
PM (TTM) 5.18%
GM 12.1%
FCFM 3.82%
ROA(3y)11.72%
ROA(5y)N/A
ROE(3y)32.38%
ROE(5y)N/A
ROIC(3y)19.2%
ROIC(5y)N/A
ROICexc(3y)19.99%
ROICexc(5y)N/A
ROICexgc(3y)25.54%
ROICexgc(5y)N/A
ROCE(3y)26.11%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.11%
OM growth 5YN/A
PM growth 3Y-1.91%
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5YN/A
F-Score7
Asset Turnover2.15
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 2.14
Debt/EBITDA 1
Cap/Depr 199.03%
Cap/Sales 1.6%
Interest Coverage 11.49
Cash Conversion 70.13%
Profit Quality 73.74%
Current Ratio 1.76
Quick Ratio 1.69
Altman-Z 6.44
F-Score7
WACC9.18%
ROIC/WACC2.08
Cap/Depr(3y)170.58%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.42%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.19%
EPS Next Y0.7%
EPS Next 2Y5.4%
EPS Next 3Y11.93%
EPS Next 5Y7.99%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%33.15%
Revenue Next Year8.94%
Revenue Next 2Y8.67%
Revenue Next 3Y13.22%
Revenue Next 5Y5.45%
EBIT growth 1Y-0.33%
EBIT growth 3Y9.22%
EBIT growth 5YN/A
EBIT Next Year57.6%
EBIT Next 3Y23.2%
EBIT Next 5Y19.43%
FCF growth 1Y-15.21%
FCF growth 3Y25.55%
FCF growth 5YN/A
OCF growth 1Y-4.65%
OCF growth 3Y24.12%
OCF growth 5YN/A

EVERUS CONSTRUCTION GROUP / ECG FAQ

Can you provide the ChartMill fundamental rating for EVERUS CONSTRUCTION GROUP?

ChartMill assigns a fundamental rating of 5 / 10 to ECG.


What is the valuation status for ECG stock?

ChartMill assigns a valuation rating of 4 / 10 to EVERUS CONSTRUCTION GROUP (ECG). This can be considered as Fairly Valued.


How profitable is EVERUS CONSTRUCTION GROUP (ECG) stock?

EVERUS CONSTRUCTION GROUP (ECG) has a profitability rating of 4 / 10.


What is the valuation of EVERUS CONSTRUCTION GROUP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EVERUS CONSTRUCTION GROUP (ECG) is 34.13 and the Price/Book (PB) ratio is 11.97.


What is the expected EPS growth for EVERUS CONSTRUCTION GROUP (ECG) stock?

The Earnings per Share (EPS) of EVERUS CONSTRUCTION GROUP (ECG) is expected to grow by 0.7% in the next year.